Recent Updates
Recently added Catalysts

Electronic medication reconciliation

Phase 3

Medication Reconciliation | Unknown | Other |Healthcare Services Group|Last Updated: Mar 5, 2014

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedNO_TREATMENT_CONTROLLEDDMC
Total Trials1
Total Enrollment4,818
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01195051Medication Reconciliation Technology to Improve Quality of Transitional CarePHASE3 COMPLETED 4,818Nov 1, 2010Apr 1, 2012Mar 5, 20141 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Reconciliation of outpatient medications
Hospital admission, transfer, and discharge; 1 year

Number and fraction of outpatient medications prescribed or addressed as to why prescribing did not occur. Number and fraction of cases with MR by a pharmacist. Number and fraction of cases undergoing any MR. Number and fraction of cases where any outpatient medications were not prescribed or addressed as to why prescribing did not occur.

Secondary Endpoints
Measurement of potential for harm and potential severity of harm
Hospital discharge; 1 year
Measurement and analysis of providers' perspectives
Start and end of trial; 1 year
Measurement and analysis of patients' perspectives
Hospital discharge; 1 year
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelPARALLEL
PurposeHEALTH_SERVICES_RESEARCH
Treatment Arms
ArmTypeDescription
Electronic medication reconciliationEXPERIMENTALProviders have access to a new, computer-based application to facilitate documentation and prescribing of outpatient medications in the inpatient setting.
ControlNO_INTERVENTION -
Interventions
NameTypeDescription
Electronic medication reconciliationOTHERA new, computer-based application will be used to document and prescribe outpatient medications in the inpatient setting.
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — N/A
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: * Patients admitted to the Medicine Service during a 12-month period * Physicians who provide inpatient or ambulatory care for participating patients. * Pharmacists who provide care for participating patients. Exclusion Criteria: * Patients admitted but not seen in a primary-c...

Countries:United States
Unlock Eligibility Criteria